Trial Profile
Immunological Comparison of AIT and SCIT Immunotherapy Against Grass Pollen
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary) ; Grass pollen allergy immunotherapy (Primary)
- Indications Grass pollen hypersensitivity
- Focus Pharmacodynamics
- 03 Jul 2013 New trial record